Amsterdam-based Advanced Microbiome Interventions (AMI), a healthtech startup that develops innovative drugs for type 1 diabetes and other autoimmune diseases, announced that it has received a €300K convertible loan from Innovatiefonds Noord-Holland. 

Read the full article here >